What is the size of the U.S. alternate-site infusion therapy market?
Driven by heightened emphasis on cost-effectiveness and cost-containment, and the desire of patients to resume normal lifestyles and work activities while recovering from illness, the alternate-site infusion therapy sector continues to expand. It is currently estimated to represent approximately $9 – 11 billion dollars a year in U.S. health care expenditures serviced by 700 to 1,000 infusion pharmacies. However, the overall contribution of home infusion therapy to the health care system is certainly much more significant. The cost of infusion therapy administered in the home or alternate-site care setting is far less than the cost of inpatient treatment.
